118 related articles for article (PubMed ID: 3985850)
1. Lidocaine plasma concentrations following administration of intraoral lidocaine solution.
Greenblatt DJ; Benjamin DM; Willis CR; Harmatz JS; Zinny MA
Arch Otolaryngol; 1985 May; 111(5):298-300. PubMed ID: 3985850
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of lidocaine and its principal metabolites during intermittent epidural anesthesia.
Inoue R; Suganuma T; Echizen H; Ishizaki T; Kushida K; Tomono Y
Anesthesiology; 1985 Sep; 63(3):304-10. PubMed ID: 4025891
[TBL] [Abstract][Full Text] [Related]
3. Effect of 4% topical lidocaine applied to the face on the serum levels of lidocaine and its metabolite, monoethylglycinexylidide.
Oni G; Brown S; Burrus C; Grant L; Watkins J; Kenkel M; Barton F; Kenkel J
Aesthet Surg J; 2010; 30(6):853-8. PubMed ID: 21131461
[TBL] [Abstract][Full Text] [Related]
4. Chromatographic determination of free lidocaine and its active metabolites in plasma from patients under epidural anesthesia.
Kakiuchi Y; Fukuda T; Miyabe M; Homma M; Toyooka H; Kohda Y
Int J Clin Pharmacol Ther; 2002 Nov; 40(11):493-8. PubMed ID: 12698986
[TBL] [Abstract][Full Text] [Related]
5. Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.
Powell JR; Foster J; Patterson JH; Cross R; Wargin W
Clin Pharm; 1986 Dec; 5(12):993-8. PubMed ID: 3802729
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man.
Bennett PN; Aarons LJ; Bending MR; Steiner JA; Rowland M
J Pharmacokinet Biopharm; 1982 Jun; 10(3):265-81. PubMed ID: 7175699
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolism of lidocaine in patients with renal failure.
Collinsworth KA; Strong JM; Atkinson AJ; Winkle RA; Perlroth F; Harrison DC
Clin Pharmacol Ther; 1975 Jul; 18(1):59-64. PubMed ID: 1149363
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
9. Maternal, fetal, and neonatal metabolism of lidocaine.
Kuhnert BR; Knapp DR; Kuhnert PM; Prochaska AL
Clin Pharmacol Ther; 1979 Aug; 26(2):213-20. PubMed ID: 455889
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.
Drayer DE; Lorenzo B; Werns S; Reidenberg MM
Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of lidocaine and its principal metabolites during continuous epidural infusion of lidocaine with or without epinephrine.
Kihara S; Miyabe M; Kakiuchi Y; Takahashi S; Fukuda T; Kohda Y; Toyooka H
Reg Anesth Pain Med; 1999; 24(6):529-33. PubMed ID: 10588557
[TBL] [Abstract][Full Text] [Related]
12. Plasma lidocaine, monoethylglycinexylidide, and glycinexylidide concentrations after epidural administration in geriatric patients.
Fukuda T; Kakiuchi Y; Miyabe M; Okubo N; Yaguchi Y; Kohda Y; Toyooka H
Reg Anesth Pain Med; 2000; 25(3):268-73. PubMed ID: 10834781
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion.
Estes NA; Manolis AS; Greenblatt DJ; Garan H; Ruskin JN
Am Heart J; 1989 May; 117(5):1060-4. PubMed ID: 2711965
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide.
Strong JM; Mayfield DE; Atkinson AJ; Burris BC; Raymon F; Webster LT
Clin Pharmacol Ther; 1975 Feb; 17(2):184-94. PubMed ID: 1122677
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of monoethylglycinexylidide during and after breast augmentation.
Rygnestad T; Samdal F
Plast Reconstr Surg; 2000 Sep; 106(3):728-31. PubMed ID: 10987485
[TBL] [Abstract][Full Text] [Related]
16. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function.
Oellerich M; Raude E; Burdelski M; Schulz M; Schmidt FW; Ringe B; Lamesch P; Pichlmayr R; Raith H; Scheruhn M
J Clin Chem Clin Biochem; 1987 Dec; 25(12):845-53. PubMed ID: 3443824
[TBL] [Abstract][Full Text] [Related]
17. Comparison of five commonly-available, lidocaine-containing topical anesthetics and their effect on serum levels of lidocaine and its metabolite monoethylglycinexylidide (MEGX).
Oni G; Brown S; Kenkel J
Aesthet Surg J; 2012 May; 32(4):495-503. PubMed ID: 22452841
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of lidocaine and its active metabolites in dogs.
Wilcke JR; Davis LE; Neff-Davis CA; Koritz GD
J Vet Pharmacol Ther; 1983 Mar; 6(1):49-57. PubMed ID: 6854732
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravenous, subcutaneous, and topical administration of lidocaine hydrochloride and metabolites 3-hydroxylidocaine, monoethylglycinexylidide, and 4-hydroxylidocaine in horse.
Soma LR; You Y; Robinson MA; Boston RC
J Vet Pharmacol Ther; 2018 Dec; 41(6):825-837. PubMed ID: 30028024
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats.
Ko JC; Maxwell LK; Abbo LA; Weil AB
J Vet Pharmacol Ther; 2008 Aug; 31(4):359-67. PubMed ID: 18638297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
